Related references
Note: Only part of the references are listed.Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition A Meta-Analysis
Markus P. Schneider et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
ANNALS OF INTERNAL MEDICINE (2009)
Prevention of Recurrent Lone Atrial Fibrillation by the Angiotensin-II Converting Enzyme Inhibitor Ramipril in Normotensive Patients
Fabio Belluzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Valsartan for Prevention of Recurrent Atrial Fibrillation
Marcello Disertori et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation
Roberto Fogari et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis
Mhamad B. Jibrini et al.
AMERICAN JOURNAL OF THERAPEUTICS (2008)
Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT(1) receptor blockade in human atrial myocardium
Dirk von Lewinski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial
Roland E. Schmieder et al.
JOURNAL OF HYPERTENSION (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S. Yusuf et al.
LANCET (2008)
Telmisartan to prevent recurrent stroke and cardiovascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction.
Barry M. Massie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Coronary artery disease - Impact of ramipril on the incidence of atrial fibrillation: Results of the Heart Outcomes Prevention Evaluation study
Omid Salehian et al.
AMERICAN HEART JOURNAL (2007)
Candesartan in the prevention of relapsing atrial fibrillation
Arnljot Tveit et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey
John P. A. Ioannidis et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation
Yuehui Yin et al.
EUROPEAN HEART JOURNAL (2006)
Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation
Kishlay Anand et al.
AMERICAN HEART JOURNAL (2006)
ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation
A Boldt et al.
BASIC RESEARCH IN CARDIOLOGY (2006)
Losartan and prevention of atrial fibrillation recurrence in hypertensive patients
R Fogari et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis
JS Healey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol -: The Losartan Intervention For End point reduction in hypertension (LIFE) study
K Wachtell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:: Results from the Valsartan Heart Failure Trial (Val-HeFT)
AP Maggioni et al.
AMERICAN HEART JOURNAL (2005)
The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases:: Meta-analysis of randomized controlled clinical trials
AH Madrid et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2004)
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction - Insight from the studies of left ventricular dysfunction (SOLVD) trials
E Vermes et al.
CIRCULATION (2003)
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation - Results of a prospective and controlled study
KC Ueng et al.
EUROPEAN HEART JOURNAL (2003)
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
S Stewart et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study
AH Madrid et al.
CIRCULATION (2002)
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
DS Li et al.
CIRCULATION (2001)
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data
F Pizzetti et al.
HEART (2001)
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation
H Nakashima et al.
CIRCULATION (2000)
Share Paper
